CME/CE from MPR


MPR delivers practical, up-to-date drug information to healthcare professionals. Using the expertise gained from 25 years of providing point-of-care drug tools, MPR has now created a drug review course exclusively for myCME.com. See below for a list of each quarter's courses. Click here to visit MPR's website.




Latest Courses

Clinical Review

New-Drug Review from MPR (April 2014)

1.00 Credits


MPR Drug News


Verapamil May Help Lower Glucose Levels in Diabetic Patients

A new study has found that verapamil - used to treat high blood pressure, irregular heartbeat and migraine - can lower fasting glucose levels in diabetes patients.

Alzheimer's Drug Shortage Resolved

The Food and Drug Administration (FDA) has reported that the Namenda XR (memantine HCl) extended-release capsules shortage has been resolved as of February 11, 2016.

No Difference in Efficacy Between Generic Seizure Drugs, Study Show

No detectable difference was measured in clinical effects when two generic antiepileptic drugs were tested among patients, results from a study has shown.

Teva Launches Generic Taxotere Injection

Teva announced the launch of Docetaxel Injection, the generic version of Taxotere Injection Concentrate.

Recall: Impurities Detected in Drug Used to Treat CKD Patients

Teva announced a voluntary recall of one lot of Paricalcitol 1mcg capsules, the generic version of AbbVie's Zemplar.